國立高雄大學圖資館 |

Language: English

Back

Drug development for cancer and diabetesa path to 2030 /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Drug development for cancer and diabetesedited by K. Saravanan ... [et al.].
Reminder of title:	a path to 2030 /
other author:	Saravanan, K.
Published:	Burlington, ON, Canada ;Apple Academic Press,c2021.
Description:	1 online resource.
Subject:	Antineoplastic agentsDevelopment.
Online resource:	https://www.taylorfrancis.com/books/9780429330490
ISBN:	9780429330490$q(electronic bk.)

Drug development for cancer and diabetesa path to 2030 /
Drug development for cancer and diabetesa path to 2030 /[electronic resource] :edited by K. Saravanan ... [et al.]. - Burlington, ON, Canada ;Apple Academic Press,c2021. - 1 online resource.

Includes bibliographical references and index.

"Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases. It is structured in two parts. Part I consists of chapters that explores cancer cell cycle checkpoints, cancer biomarkers, essential drug properties, stages in anti-cancer drug development, and various bioactives that are effective against cancer. Part II presents a complete coverage of important advances and research discoveries in antidiabetic drugs. It details the potentials of medicinal plants and phytocompounds as sources for antidiabetic drugs and highlights the ethnobotanical basis of the compounds. With chapters written by professionals in the field of phytochemistry and pharmacology from key institutions around the world, this volume provides a wide coverage and will be useful especially for scientists in pharmaceutical field. Key features: presents novel discoveries and mechanisms for the treatment of cancer and diabetes, details the role of plants for the treatment and management of cancer and diabetes, discusses the role of phytocompounds as ligands for cancer and diabetic targets, reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs, explores the green biosynthesis of nanoparticles and their efficiency in the treatment of diabetes and cancer."--

ISBN: 9780429330490$q(electronic bk.)Subjects--Topical Terms:

275191
Antineoplastic agents
--Development.

LC Class. No.: RS431.A64 / D78 2020

Dewey Class. No.: 616.99/4061

Drug development for cancer and diabetesa path to 2030 /
LDR:02722cmm a2200337 a 4500 001 624129
003 FlBoTFG
005 20201022041822.0
006 m o d
007 cr cnu---unuuu
008 221226s2021 onc ob 001 0 eng d
020 $a 9780429330490$q(electronic bk.)
020 $a 0429330499$q(electronic bk.)
020 $a 9781000639988$q(electronic bk.)
020 $a 1000639983$q(electronic bk.)
020 $a 9781000649949$q(electronic bk.)
020 $a 1000649946$q(electronic bk.)
020 $a 9781000644968$q(electronic bk.)
020 $a 1000644960$q(electronic bk.)
020 $z 9781771888608$q(hardcover)
035 $a 9780429330490
040 $a OCoLC-P $b eng $c OCoLC-P
041 0 $a eng
050 0 0 $a RS431.A64 $b D78 2020
082 0 4 $a 616.99/4061 $2 23
245 0 0 $a Drug development for cancer and diabetes $h [electronic resource] : $b a path to 2030 / $c edited by K. Saravanan ... [et al.].
260 $a Burlington, ON, Canada ; $a Palm Bay, Fl., USA : $b Apple Academic Press, $c c2021.
300 $a 1 online resource.
504 $a Includes bibliographical references and index.
520 $a "Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases. It is structured in two parts. Part I consists of chapters that explores cancer cell cycle checkpoints, cancer biomarkers, essential drug properties, stages in anti-cancer drug development, and various bioactives that are effective against cancer. Part II presents a complete coverage of important advances and research discoveries in antidiabetic drugs. It details the potentials of medicinal plants and phytocompounds as sources for antidiabetic drugs and highlights the ethnobotanical basis of the compounds. With chapters written by professionals in the field of phytochemistry and pharmacology from key institutions around the world, this volume provides a wide coverage and will be useful especially for scientists in pharmaceutical field. Key features: presents novel discoveries and mechanisms for the treatment of cancer and diabetes, details the role of plants for the treatment and management of cancer and diabetes, discusses the role of phytocompounds as ligands for cancer and diabetic targets, reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs, explores the green biosynthesis of nanoparticles and their efficiency in the treatment of diabetes and cancer."-- $c Provided by publisher.
588 $a Description based on print version record.
650 0 $a Antineoplastic agents $x Development. $3 275191
650 0 $a Herbs $x Therapeutic use. $3 192750
650 0 $a Medicinal plants. $3 210655
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Diabetes $x Treatment. $3 276740
650 0 $a Cancer $x Chemotherapy $x Research. $3 926466
650 0 $a Diabetes $x Chemotherapy $x Research. $3 926467
700 1 $a Saravanan, K. $3 926465
856 4 0 $u https://www.taylorfrancis.com/books/9780429330490